A Cross-Sectional Study of Quality of Life Among Brazilian Adults With Type 1 Diabetes Treated With Insulin Glargine: Findings and Implications.


Journal

Clinical diabetes : a publication of the American Diabetes Association
ISSN: 0891-8929
Titre abrégé: Clin Diabetes
Pays: United States
ID NLM: 8406985

Informations de publication

Date de publication:
2022
Historique:
entrez: 19 8 2022
pubmed: 20 8 2022
medline: 20 8 2022
Statut: ppublish

Résumé

This article describes a cross-sectional study involving 401 adults with type 1 diabetes treated with insulin glargine in Minas Gerais, Brazil. Health-related quality of life was assessed, and worse scores were found to be associated with a low level of education, self-perceived health reported as poor/very poor, being bedridden and not physically exercised, having seen a doctor more than four times in the past year, and having reported comorbidities and episodes of hypoglycemia.

Identifiants

pubmed: 35983417
doi: 10.2337/cd21-0068
pii: CD210068
pmc: PMC9331629
doi:

Types de publication

Journal Article

Langues

eng

Pagination

312-326

Informations de copyright

© 2022 by the American Diabetes Association.

Références

Diabetes Res Clin Pract. 2017 Feb;124:11-19
pubmed: 28081448
Value Health. 2018 Feb;21(2):176-184
pubmed: 29477399
Med Decis Making. 2016 Feb;36(2):253-63
pubmed: 26492896
Hosp Pract (1995). 2020 Mar 14;48(2):51-67
pubmed: 32196395
Clinicoecon Outcomes Res. 2016 Oct 07;8:559-571
pubmed: 27785079
Diabetes Ther. 2020 Apr;11(4):939-950
pubmed: 32152932
JAMA. 2017 Jul 4;318(1):31-32
pubmed: 28672298
Intern Med. 2007;46(13):937-43
pubmed: 17603230
Ther Adv Endocrinol Metab. 2018 Jun 22;9(8):241-254
pubmed: 30181850
Health Qual Life Outcomes. 2018 Feb 02;16(1):27
pubmed: 29394942
Patient. 2018 Aug;11(4):377-389
pubmed: 29322308
Diabetes Res Clin Pract. 2017 Dec;134:44-52
pubmed: 28951342
Lancet. 2021 Dec 19;396(10267):2019-2082
pubmed: 33189186
Cochrane Database Syst Rev. 2021 Mar 4;3:CD013498
pubmed: 33662147
Cad Saude Publica. 2019 Sep 16;35(9):e00087219
pubmed: 31531516
Diabetes Care. 2019 Jan;42(Suppl 1):S61-S70
pubmed: 30559232
J Med Econ. 2011;14(5):646-55
pubmed: 21854191
Postgrad Med J. 2016 Mar;92(1085):152-64
pubmed: 26842973
J Comp Eff Res. 2017 Sep;6(6):519-527
pubmed: 28960085
Health Qual Life Outcomes. 2015 Dec 24;13:204
pubmed: 26703221
BMJ Glob Health. 2019 Jun 11;4(3):e001410
pubmed: 31263585
Acta Diabetol. 2010 Jun;47(2):137-45
pubmed: 19655083
Diabetes Care. 2019 Jan;42(Suppl 1):S139-S147
pubmed: 30559238
PLoS One. 2019 Oct 16;14(10):e0224012
pubmed: 31618268
Diabetes Metab. 2010 Sep;36(4):305-11
pubmed: 20483647
Curr Med Res Opin. 2021 Sep;37(9):1529-1545
pubmed: 34166174
Diabetes Care. 2006 Mar;29(3):725-31
pubmed: 16505540
J Gen Intern Med. 2021 Aug;36(8):2414-2426
pubmed: 33742305
Expert Rev Pharmacoecon Outcomes Res. 2017 Apr;17(2):109-119
pubmed: 28403729
Cochrane Database Syst Rev. 2020 Nov 9;11:CD005613
pubmed: 33166419
PLoS One. 2019 Jun 25;14(6):e0217655
pubmed: 31237873
Diabetes Care. 2018 May;41(5):963-970
pubmed: 29475843
Diabetes Care. 2018 Jun;41(6):1299-1311
pubmed: 29739814
Curr Diab Rep. 2016 Aug;16(8):67
pubmed: 27287017
BMC Public Health. 2018 Aug 8;18(1):989
pubmed: 30089461
Acta Diabetol. 2015 Aug;52(4):649-62
pubmed: 25585592
Health Qual Life Outcomes. 2010 Feb 04;8:18
pubmed: 20132542
Diabetol Metab Syndr. 2017 Jan 28;9:9
pubmed: 28149328
Appl Health Econ Health Policy. 2014 Feb;12(1):19-32
pubmed: 24385261
BioDrugs. 2018 Dec;32(6):585-606
pubmed: 30499082
Diabetes Ther. 2016 Jun;7(2):241-58
pubmed: 27048292
BMJ Open. 2013 Sep 18;3(9):e003336
pubmed: 24052610
Acta Diabetol. 2016 Oct;53(5):717-26
pubmed: 27093968
Adv Rheumatol. 2019 Nov 14;59(1):48
pubmed: 31727164
Expert Rev Clin Pharmacol. 2016;9(5):739-46
pubmed: 26873164
Issues Emerg Health Technol. 2003 Nov;(52):1-4
pubmed: 14626260
Front Public Health. 2021 Jun 24;9:671961
pubmed: 34249838
Hosp Pract (1995). 2021 Oct;49(4):266-272
pubmed: 33734004
Diabetes Res Clin Pract. 2016 Nov;121:62-68
pubmed: 27662040
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Diabetes Res Clin Pract. 2016 Jun;116:237-43
pubmed: 27321341
PLoS One. 2018 Apr 12;13(4):e0194801
pubmed: 29649221
Diabetes Care. 2000 Nov;23(11):1666-71
pubmed: 11092290
Diabetes Care. 2019 Jan;42(Suppl 1):S7-S12
pubmed: 30559227
Diabetol Metab Syndr. 2019 Jan 03;11:2
pubmed: 30622653

Auteurs

Paulo H R F Almeida (PHRF)

Graduate Program in Medicines and Pharmaceutical Services, Department of Social Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Brian Godman (B)

Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, U.K.
Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.

Vania Dos Santos Nunes-Nogueira (V)

Department of Internal Medicine, São Paulo State University Medical School, São Paulo, Brazil.

Lívia L P de Lemos (LLP)

Graduate Program in Public Health, Faculty of Medicine, Department of Preventive and Social Medicine, Federal University of Minas Gerais Belo Horizonte, Minas Gerais, Brazil.

Francisco de Assis Acúrcio (F)

Graduate Program in Medicines and Pharmaceutical Services, Department of Social Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Graduate Program in Public Health, Faculty of Medicine, Department of Preventive and Social Medicine, Federal University of Minas Gerais Belo Horizonte, Minas Gerais, Brazil.
SUS Collaborating Centre for Technology Assessment and Excellence in Health, Belo Horizonte, Minas Gerais, Brazil.

Augusto A Guerra-Junior (AA)

Graduate Program in Medicines and Pharmaceutical Services, Department of Social Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
SUS Collaborating Centre for Technology Assessment and Excellence in Health, Belo Horizonte, Minas Gerais, Brazil.

Vânia E de Araújo (VE)

Graduate Program in Medicines and Pharmaceutical Services, Department of Social Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
SUS Collaborating Centre for Technology Assessment and Excellence in Health, Belo Horizonte, Minas Gerais, Brazil.
Department of Dentistry, Pontifical Catholic University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Alessandra M Almeida (AM)

Graduate Program in Medicines and Pharmaceutical Services, Department of Social Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
SUS Collaborating Centre for Technology Assessment and Excellence in Health, Belo Horizonte, Minas Gerais, Brazil.

Juliana Alvares-Teodoro (J)

Graduate Program in Medicines and Pharmaceutical Services, Department of Social Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
SUS Collaborating Centre for Technology Assessment and Excellence in Health, Belo Horizonte, Minas Gerais, Brazil.

Classifications MeSH